Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 6, 2007

Curis, Inc.


(Exact name of registrant as specified in charter)

 

Delaware

 

000-30347

 

04-3505116

(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

45 Moulton Street, Cambridge, MA

 

02138

(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (617) 503-6500

Not Applicable


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 6, 2007, the compensation committee (the “Compensation Committee”) of the board of directors of Curis, Inc. (the “Company”) determined the annual base salaries, effective as of June 6, 2007, of each named executive officer listed below, in the amounts listed below.

 

Named Executive Officer

   Annual Salary

Michael P. Gray, Chief Operating and Chief Financial Officer

   $ 300,000

Mark W. Noel, Vice President, Technology Management and Business Development

   $ 210,000

Daniel R. Passeri, President and Chief Executive Officer

   $ 400,000

In addition, on June 6, 2007, the Compensation Committee determined the annual base salary, effective as of June 6, 2007, of Changgeng Qian, Ph.D., M.D., the Company’s Vice President, Discovery and Preclinical Research, to be $235,000.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Curis, Inc.
Date: June 8, 2007     By:   /S/ MICHAEL P. GRAY
       

Michael P. Gray

Chief Operating Officer and Chief Financial Officer